The presence of 0.75 μM N-ethylmaleimide (NEM) during irradiation of synchronous HeLa cells at different stages of their cycle enhances cell killing (i.e., sensitizes) in early G1 and late S, but does not affect mitotic cells or cells at the G1/ S border. The effect is primarily on the shoulder of the survival curve, rather than its slope. NEM given immediately before or after irradiation is as effective as during irradiation. When given as a function of time after exposure the effect decreases in magnitude, cells becoming insensitive to NEM more rapidly in S than in G1. The drug is also effective if administered prior to irradiation, the effect generally decreasing the longer the interval between treatment and irradiation. The addition of 1.0 mM hydroxyurea (HU) to synchronous HeLa cells in G1 showed that survival changes occur as the cells proceed through the "cell cycle" even in the absence of DNA synthesis. The changes observed are qualitatively the same to those observed previously in Chinese hamster cells. The irradiation of HU-inhibited cells in the presence of 0.75 μM NEM produced almost no variation in survival through "the cycle," the inhibited cells showing a sensitivity greater than that normally observed in mitotic cells. The results presented are consistent with the idea that NEM inhibits repair processes in the cell most likely due to its binding to a critical SH-containing enzyme(s) concerned with the repair of radiation damage.
Skip Nav Destination
Research Article| February 01 1976
The Effect of N-Ethylmaleimide on the Response to X Rays of Synchronized HeLa Cells
Warren K. Sinclair ;
Radiat Res (1976) 65 (2): 337–350.
- Views Icon Views
- Share Icon Share
- Search Site
Antun Han, Warren K. Sinclair, Bruce F. Kimler; The Effect of N-Ethylmaleimide on the Response to X Rays of Synchronized HeLa Cells. Radiat Res 1 February 1976; 65 (2): 337–350. doi: https://doi.org/10.2307/3574206
Download citation file:
Citing articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Monte Carlo Simulation of SARS-CoV-2 Radiation-Induced Inactivation for Vaccine Development
Ziad Francis, Sebastien Incerti, Sara A. Zein, Nathanael Lampe, Carlos A. Guzman, Marco Durante
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner
RITCARD: Radiation-Induced Tracks, Chromosome Aberrations, Repair and Damage
Ianik Plante, Artem Ponomarev, Zarana Patel, Tony Slaba, Megumi Hada